Skip to content
Sign in

BHC · NYSE

Bausch Health Companies (BHC) Stock Price & Fundamentals

$379.88+0.88%+$3.32End-of-day price as of Oct 9, 2026

Bausch Health Companies (BHC) closed at $379.88 on Oct 9, 2026, up 0.88% from the previous close of $376.56.

Share price, past year

1Y +8.26%

52-week range $334.11 – $381.39. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$379.88
Sep 30, 2026$372.08
Aug 31, 2026$360.78
Jul 31, 2026$338.62
Jun 30, 2026$347.32
May 29, 2026$353.88
Apr 30, 2026$368.15
Mar 31, 2026$378.46
Feb 27, 2026$365.53
Jan 30, 2026$359.81
Dec 31, 2025$356.48
Nov 28, 2025$363.79
Oct 31, 2025$363.29

Key statistics

Market cap
$142.04B
P/E (TTM)
—
EPS (TTM)
−$2.96
Revenue (TTM)
$10.85B
Net income (TTM)
−$1.10B
Shares outstanding
373.9M
Dividend yield
—
52-week range
$334.11 – $381.39

Bausch Health Companies's market cap is $142.04B, based on a share price of $379.88 and 373.9M shares outstanding as of Jun 30, 2026.

Financials

Bausch Health Companies reported revenue of $10.27B for fiscal 2025, up 6.66% from fiscal 2024.

Bausch Health Companies earned net income of $157.00M in fiscal 2025, a net margin of 1.5%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Bausch Health Companies annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$10.27B+6.7%$157.00M1.5%$0.42$1.00B
FY2024ended Dec 31, 2024$9.63B+9.9%−$46.00M−0.5%−$0.13$1.26B
FY2023ended Dec 31, 2023$8.76B+7.8%−$592.00M−6.8%−$1.62$817.00M
FY2022ended Dec 31, 2022$8.12B−3.7%−$225.00M−2.8%−$0.62−$946.00M
FY2021ended Dec 31, 2021$8.43B+5.1%−$948.00M−11.2%−$2.64$1.16B
FY2020ended Dec 31, 2020$8.03B−6.7%−$560.00M−7.0%−$1.58$809.00M
FY2019ended Dec 31, 2019$8.60B+2.6%−$1.79B−20.8%−$5.08$1.23B
FY2018ended Dec 31, 2018$8.38B−3.9%——−$11.81$1.34B
FY2017ended Dec 31, 2017$8.72B−9.8%——$6.83$2.12B
FY2016ended Dec 31, 2016$9.67B———−$6.94$1.85B
Bausch Health Companies quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$2.85B$258.00M$0.68
Q1 FY2026ended Mar 31, 2026$2.52B−$1.42B−$3.82
Q4 FY2025ended Dec 31, 2025$2.80B−$112.00M−$0.30
Q3 FY2025ended Sep 30, 2025$2.68B$179.00M$0.48
Q2 FY2025ended Jun 30, 2025$2.53B$148.00M$0.40
Q1 FY2025ended Mar 31, 2025$2.26B−$58.00M−$0.16
Q4 FY2024ended Dec 31, 2024$2.56B$93.00M$0.24
Q3 FY2024ended Sep 30, 2024$2.51B−$85.00M−$0.23

Company profile

Name
Bausch Health Companies Inc.
Ticker
BHC
Exchange
NYSE
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
2150 St. Elzear Blvd. West, Laval, Quebec, A8 H7L 4A8
Incorporated in
NJ
Fiscal year ends
December
SEC CIK
0000885590

Recent SEC filings

Frequently asked questions

What is Bausch Health Companies's stock price?

Bausch Health Companies (BHC) closed at $379.88 on Oct 9, 2026, up 0.88% from the previous close of $376.56.

What is Bausch Health Companies's market cap?

Bausch Health Companies's market cap is $142.04B, based on a share price of $379.88 and 373.9M shares outstanding as of Jun 30, 2026.

How much revenue does Bausch Health Companies make?

Bausch Health Companies reported revenue of $10.27B for fiscal 2025, up 6.66% from fiscal 2024.

Does Bausch Health Companies pay a dividend?

Bausch Health Companies's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Bausch Health Companies Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures